S'abonner

Proximal femoral nails antirotation, Gamma nails, and dynamic hip screws for fixation of intertrochanteric fractures of femur: A meta-analysis - 06/12/14

Doi : 10.1016/j.otsr.2014.07.023 
K.-L. Ma a, X. Wang b, F.-J. Luan a, H.-T. Xu a, Y. Fang c, , J. Min a, H.-X. Luan a, F. Yang a, H. Zheng a, S.-J. He a
a Yongchuan Hospital, Chongqing Medical University, Hua Road, No. 439, Yongchuan, Chongqing 402160, China 
b The Chinese Medicine Hospital of Suqian, Hengshan Road No. 1, Suqian 223800, China 
c West China Hospital, Sichuan University, Lane Sinology No. 37, Chengdu 610041, China 

Corresponding author. Department of Orthopaedics, West China Hospital of Sichuan University, Lane Sinology No. 37, Wuhou District, Chengdu 610041, China.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Which surgical strategy is the best one for intertrochanteric fractures remains a controversial issue. Dynamic hip screw (DHS) and Gamma nail were commonly used but often associated with some complications, such as fixation failure and implant-related fractures. Meanwhile, proximal femoral nail anti-rotation (PFNA) fixation has recently been developed for minimally invasive surgery to reduce the complications rate. To facilitate the clinical decision-making, we conducted an updated meta-analysis to discuss the optimal treatment of intertrochanteric fractures aiming to determine which implant gives the lower rates of blood loss, complications (peri-implant fracture, fixation failure, infection, thromboembolic), reoperation, and mortality, as well as the minimal duration related to surgery (fluoroscopic exposure, surgery and hospital stay).

Patients and methods

Seven electronic databases were searched for randomized controlled trials (including OVID, Springer, Google Scholar, PubMed, Cochrane library, Embase, and Web of Science). Fourteen studies with 1983 patients were included. The modified Jadad Scale was used to assess the methodological quality of these studies. Risk of bias in the included studies was assessed using the Cochrane Risk of Bias tool. Comparison among the three groups was based on twelve indicators, including operative time, fluoroscopy time, operative blood loss, length of hospital stays, wound infection or hematoma, pneumonia, thromboembolic complications, fixation failure, operative fracture of femur, later fracture of femur, reoperation, and mortality.

Results

(1) PFNA group versus DHS group: PFNA was associated with less blood loss (mean difference (MD) –253.86, 95% CI –270.25 to 237.47; P<0.00001) and lower rate of fixation failure (MD 0.20, 95% CI 0.07 to 0.59; P=0.004), but led to more fluoroscopy time (MD 2.11, 95% CI 1.78 to 2.43; P<0.00001). (2) PFNA group versus Gamma nail group: PFNA led to less blood loss (MD –55.30, 95% CI –60.07 to –50.53; P<0.00001), shorter fluoroscopy time (MD –0.50, 95% CI –0.55 to –0.45; P<0.00001) and length of hospital stay (MD –0.20, 95% CI –0.27 to –0.13; P<0.00001). (3) DHS group versus Gamma nail group: DHS was associated with lower rate of operative fracture of femur (MD 0.31, 95% CI 0.11 to 0.89; P=0.03), later fracture of femur (MD 0.16, 95% CI 0.06 to 0.43; P=0.0004), and reoperation (MD 0.49, 95% CI 0.27 to 0.88; P=0.02), but caused more blood loss (MD 29.49, 95% CI 8.27 to 50.70; P=0.006). In contrast, there was no difference regarding operative time, infection hematoma, pneumonia, thromboembolic events, and mortality.

Discussion

PFNA should be a priority choice for treatment of intertrochanteric fractures with minimal rate of fixation failure, less blood loss and shorter length of hospital stay. DHS has distinct advantages over Gamma nail with lower rate of plant-related complications and should be preferred device for intertrochanteric fractures. However, owing to the low quality evidence currently available, more high-quality RCTs are needed to confirm these findings.

Level of evidence

Level II.

Le texte complet de cet article est disponible en PDF.

Keywords : Intertrochanteric fractures, Dynamic hip screw, Gamma nail, Proximal femoral nail antirotation, Meta-analysis


Plan


© 2014  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 100 - N° 8

P. 859-866 - décembre 2014 Retour au numéro
Article précédent Article précédent
  • DXA-based variables and osteoporotic fractures in Lebanese postmenopausal women
  • M.-L. Ayoub, G. Maalouf, F. Bachour, A. Barakat, B. Cortet, I. Legroux-Gérot, G. Zunquin, D. Theunynck, A. Nehme, R. El Hage
| Article suivant Article suivant
  • External fixation of distal femoral fractures in adults’ multicentre retrospective study of 43 patients
  • L. Bedes, P. Bonnevialle, M. Ehlinger, R. Bertin, E. Vandenbusch, G. Piétu, SoFCOT f

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.